News
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development
Reported by The New York Times.
News
The treatment, called ivonescimab, has become a symbol of China’s rise in drug development
Reported by The New York Times.